Contact this trialFirst, we need to learn more about you.
Glucagon-like peptide-1 receptor agonist
Liraglutide for Post-Sleeve Gastrectomy Obesity in Adolescents
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing whether liraglutide can help adolescents who still have obesity 1 year or more after vertical sleeve gastrectomy lose additional weight. Eligible participants must be between 12-20.99 years old, 1-10 years post vertical sleeve gastrectomy, and have a BMI of 30 kg/m2 or >=95th percentile for age and sex. The trial will last 7 months and involve 7 study visits.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.